/PRNewswire/ -- As the COVID-19 pandemic continues to evolve, five studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting...

Related Keywords

Toronto , Ontario , Canada , United States , New York , Mannheim , Baden Wüberg , Germany , Washington , Florida , Heidelberg , American , Medizinische Fakult , Lisa Hicks , Laura Michaelis , Pinkal Desai , Medizinische Klinik , Lisak Hicks , El Rassi , Susanne Saussele , Aakriti Jain , Fuad El Rassi , Instagram , Linkedin , Emory University , Twitter , Weill Cornell Medical College , Sickle Cell Center , American Society Of Hematology , Astrazeneca , Facebook , Centers For Disease , H Lee Moffitt Cancer Center , Moffitt Cancer Center , College Of Wisconsin , Research Collaborative , Research Institute , Grady Comprehensive Sickle Cell Center , American Society , Annual Meeting , Medical College , Disease Control , Reveals Potential Risk Factors , Related Deaths , Hospitalizations Among People , Death Among Patients , Blood Disorders , Acute Leukemias , Myelodysplastic Syndromes , High Risk , Defining Role , Clinical Predictors , Adult Patients , Myelodysplastic Syndrome , Hematology Research Collaborative , Data Hub , Virtual Visits Credited , Reducing Exposure , Death Due , Sickle Cell , Comprehensive Sickle Cell , Georgia Comprehensive Sickle Cell Center , Grady Hospital , Grady Comprehensive Sickle Cell , Blood Disorders May Continue , Face High Risk , Antibody Response , Lymphoid Neoplasms , Antibody Response Seen , Second Dose , Acute Myeloid , Jeffrey Lancet , Blood Advances ,